FDA Investigator Douglas C Kovacs

Douglas C Kovacs has inspections in 18 countries as of 13 Sep 2023. Douglas C Kovacs has collaborated with a combinined 8201 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

194

Last Inspection Date:

13 Sep 2023

Investigator Role:

FDA Investigator

Redica ID:

100000754

Country:

United States of America, Japan, Hungary, Italy, France, Germany, Netherlands, Ireland, Canada, Switzerland, India, United Kingdom of Great Britain and Northern Ireland, Finland, Portugal, Argentina, Bulgaria, Czechia, Latvia

Co-Investigator(s):

Addam S Reynolds, Ademola O Daramola, Adetutu M Gidado, Alberto A Viciedo, Alicia M Mozzachio, Allen F Hall, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Codella, Amy M Cramer, Amy N Chen, Ana S Cabrera, Anastasia M Shields, Angela E Glenn, Anissa M Vargas, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Antonio M Hampton, Arsen Karapetyan, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara J Maulfar, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Barry Rothman, Bei Yu, Brandi N Mcgrady, Brandy N Lepage, Brenda S Zimmer, PhD, Brett R Havranek, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Brooke K Higgins, Burnell M Henry, Byungja E Marciante, Cara M Minelli, Carl A Anderson, Carl A Huffman, III, Carl A Perez, Cary Greene, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles J Chacko, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Cheryl A Grandinetti, Cheryl Llove Harris, Chiang Syin, PhD, Christina Capacci Daniel, PhD, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Christine W Twohy, Christopher R Czajka, Christopher T Middendorf, Colin E Tack, Concepcion Cruz, Jr, Constance Y Fears, Cory Greene, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Daniel B Arrecis, Daniel Gorski, Daniel J Brown, Daniel J Gorski, Daniel J Grabicki, Daniel J Lahar, Daniel J Min, Darren S Brown, David A Oluwo, David H Smith, David M Beltran, Dawn L Wydner, Deborah A Greco, Deborah B Goffman, Deborah B Nixon, Debra J Bennett, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Deyaa Shaheen, Dinesh Kumar, Don H Bark, PhD, Dorothy J Denes, Douglas A Campbell, Douglas C Kovace, Douglas C Kovees, Dr. Barbara D Paul, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward D Harris, Edwardstine J Reese, Eileen A Liu, Elizabeth P Mayer, Emest F Bizjak, Emmanuel J Ramos, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Erin D Mccaffrery, Erin M Miller, Ernie F Bizkaj, Esteban Beltran, Farhana Khan, Francis A Guidry, Frank J Marciniak, Frank Wackes, Freddy Ortiz Colon, Frederick Razzack, Frederick Razzaghi, Gavin T Cua, George J Flynn, George M Ibrahim, George Pyramides, Gerald B Seaborn, Jr, Gianine E Delade, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hassan Ali, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, Himanshu Gupta, PhD, Hitesh R Patel, Ifueko Osemwota, Ivis L Negron, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Lane, James D Hildreth, James R Birkenstamm, Janet A Rajan, Jason M Sluzynski, Javier E Santos, Javier O Vega, Jawaid Hamid, Jay B Shah, Jay T Wong, Jean M Kelahan, Jean M Mulinde, MD, Jeffery B Medwid, PhD, Jeffrey A Sommers, Jeffrey J Ebersole, Jeffrey J, Ebersole, Jennifer D Hollstrom, Jennifer R Johnson, Jessica S Estriplet, Jill M Sooter, Jill Mielziner, Joan A Loreng, Jogy George, John P Mistler, Johnna L Bleem, Joie A Navarrete, Jonathan S Helfgott, Jonee J Mearns, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph R Strelnik, Josh Renzon Ramilo, Joshua P Wireman, Jot R Klena, Joy R Kelna, Joy Rkozlowski Klena, Juanita P Versace, Julie D Bringger, Junho Pak, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Karyn M Campbell, Kassa Ayalew, MD, Katherine E Jacobitz, Kathryn E Ogger, Kathy E Craven, Kathy E Noe, Keith M Reilley, Keith M Reilly, Kelley L Clark, Kelli F Dobilas, Kelli F Regenye, Kelli Regente, Kellia N Hicks, Kelly I Anderson, Kenneth H Williams, Kerry A Kurdilla, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, King, Kinh Q Mac, Kinh Qouc Mac, Ko U Min, Krishnaiah Yellela, Kristen D Evans, Kristina Nastovski, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Larry Johnson, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Lauren E Burke, Lauren E Sexton, Lauren E Skokan, Lauren L Vajo, Lawrence R Johnson, LCDR Debra Emerson, LCDR Michael H Tollon, Leon L Law, Li Li, Liatte Kreuger, PharmD, Liattle Krueger, Linda Thai, Lisa B Hall, Lisa Harlan, Lisa Mathew, Lisa Shin, Loretta Nemchik, Lucas B Leake, Luis A Dasta, Luis M Burgos Medero, Lydia Erosas Marty, Lydia Irosas Marty, Lynda L Perry, PhD, Manhar R Patel, Maotang Xhou, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret L Bolte, Margaret M Annes, Margaret M Sands, Maria Estrella, Maria Manzoni, PhD, Maria Pkelly Doggett, MBA, Marie Bbuen Bigornia, Marjorie D Schultz, Mark E Parmon, Mark G Peterson, Marvin D Jones, Matt D Suedkamp, Matthew A Spataro, Matthew B Casale, Matthew Sparato, Mayar M Mussa, Megan A Haggerty, Meisha Waters, Melba T Rivera, Melba Trivera Clavell, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Merril E Racke, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael J Verdi, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele L Forster, PhD, Michele Perry Williams, Miguel A Martinez, Mihaly S Ligmond, Milva E Melendez, Milva E Meléndez, Minh D Phan, Misty D Harvey, Mobin A Tawakkul, Monica M Mcclure, Monika Borkowska, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Nadeem I Chaudhry, Nancy F Scheraga, Nancy G Schmidt, Nancy L Rolli, Nancy M Espinal, Nancy Roll, Nancy Sheraga, Neal L Adams, Nelson A Rodriguez, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Nicole A Lloyd, Nicole E Knowlton, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj Mehta, Omotunde O Osunsanmi, Parul M Patel, Patrice S Hall, Patricia D Stahnke, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Peter C Chow, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pushpa S Jayasekara, Qin Xu, Ralph H Vocque, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Regina T Brown, Richard D Manney, Richard E Needham, Richard H Penta, Richard Jay Tucker, RS, Richard W Thornton, Richard W Thorntton, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert M Barbosa, Robert Sharpnack, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Rochelle L Campbell, Rochelle L Cross, Rodney G Raiford, Rodney T Allnutt, Rodrigo Vilchez, Rose Ljean Mary, Roy Baby, Russell J Glapion, Russell K Riley, Sachinkumar V Patel, Saleem A Akhtar, Samir C Gala, Sandra A Boyd, Sandra A Hughes, Sandra Kershaw, Santos E Camara, Sarah Adella Fave, Sarah E Mcmullen, Satheesh K Podaralla, Satheesh Thomas, Schultz, Scott T Ballard, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Shawn E Larson, Sherri J Liu, Sherry G Bous, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Simone E Pitts, Sinai Davis, Sneha S Patel, Sonia R Peterson, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Steven A Gonzales, Steven C Madzo, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Sunita Iyer, Susan M Halsted, Susan M Jackson, Susanna E Ford, Analyst, Susant Hadman, Taichun Qin, PhD, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Bizjak, Tara R Gooen, Tekalign Wondimu, Temar Q Williams, Teresa I Navas, Terri L Dodds, Theodore N Sietsema, Thomas J Arista, Tonia F Bernard, Tonya R Johnson, Torrance J Slayton, Toyin B Oladimeji, Travis S Bradley, Tressa T Lewis, Tyanna N Hadley, Tynna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie C Reed, Valerie L Whipp, Valerie Reed, Vera M Anderson, Veronica Fuentes, MS, Victoria Spivak, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Wayne J Meyer, Wei Wang, PhD, Wendy G Tan, PhD, William J Muszynski, William R Chang, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Xiuju Lu, Yangmin Ning, Yasamin Ameri, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zachary L Miller, Zakaria I Ganiyu, Zhijin Chen

Douglas C Kovacs's Documents

Publish Date	Document Type	Title
April, 2004	EIR	Hikma Pharmaceuticals USA, Inc. - EIR, 2004-04-15
March, 2001	FDA 483	Actavis Elizabeth LLC - Form 483, 2001-03-12
September, 2001	EIR	The P.F. Laboratories Inc. - EIR, 2001-09-21
March, 2003	FDA 483	Ivax Pharmaceuticals Inc - Form 483, 2003-03-07
July, 2004	FDA 483	Mead Johnson & Company, LLC - Form 483, 2004-07-23
September, 2005	EIR	Eli Lilly And Co. Limited - EIR, 2005-09-15
August, 2013	FDA 483 Response	ImprimisRx NJ - Form 483R, 2013-09-03
June, 2004	FDA 483 Response	Pliva, Inc. - Form 483R, 2004-06-16
November, 2008	FDA 483	DERMARITE INDUSTRIES, LLC - Form 483, 2008-11-17
June, 2000	FDA 483	Halo Pharmaceutical Inc - Form 483, 2000-06-20
February, 2013	FDA 483 Response	Actavis Elizabeth LLC - Form 483R, 2013-03-08
January, 2003	EIR	Actavis Elizabeth LLC - EIR, 2003-01-15
June, 2011	FDA 483	Genzyme Corporation - Form 483, 2011-06-21
April, 2003	FDA 483	Penick Corp - Form 483, 2003-04-03
June, 2003	EIR	Unigene Laboratories, Inc. - EIR, 2003-06-16
October, 2003	FDA 483	Halo Pharmaceutical Inc - Form 483, 2003-10-24
August, 2012	EIR	Novartis Pharmaceuticals Corporation - EIR, 2012-08-23
July, 2003	FDA 483 Response	MERCK SERONO SPA - Form 483R, 2003-08-01
August, 2011	FDA 483	Englewood Lab, Inc. - Form 483, 2011-08-25
May, 2001	EIR	SGS North America Inc. - EIR, 2001-05-23
May, 2001	FDA 483 Response	SGS North America Inc. - Form 483R, 2001-06-15
August, 2003	FDA 483 Response	Actavis Totowa LLC - Form 483R, 2003-09-19
February, 2000	EIR	Novartis Pharmaceuticals Corporation - EIR, 2000-12-21
March, 2008	EIR	Discovery Laboratories Inc. - EIR, 2008-03-25
September, 2002	EIR	Ivax Pharmaceuticals Inc - EIR, 2002-09-19
March, 2000	EIR	I S P Van Dyk Inc - EIR, 2000-03-09
February, 2008	FDA 483	Hoffmann La Roche Inc - Form 483, 2008-02-05
June, 2000	FDA 483 Response	Knoll Pharmaceutical Company - Form 483R, 2000-06-23
December, 2000	FDA 483 Response	Reed-Lane, Inc. - Form 483R, 2000-12-21
January, 2002	EIR	Abbott Laboratories - EIR, 2002-01-11
October, 2002	FDA 483 Response	DMV International - Form 483R, 2002-10-31
November, 2000	FDA 483 Response	Novus Fine Chemicals - Form 483R, 2000-12-01
June, 2002	FDA 483	Ivax Pharmaceuticals Inc - Form 483, 2002-06-20
July, 2002	EIR	Pliva, Inc. - EIR, 2002-07-26
December, 2007	EIR	Ranbaxy, Inc. - EIR, 2007-12-19
October, 2002	EIR	DMV International - EIR, 2002-10-17
April, 2000	FDA 483 Response	TEVA Pharmaceuticals USA Inc - Form 483R, 2000-05-10
May, 2018	FDA 483	HOVIONE FARMACIENCIA, S.A. - Form 483, 2018-05-18
September, 2003	EIR	Ingenus Pharmaceuticals NJ, LLC - EIR, 2003-09-19
April, 2003	EIR	Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - EIR, 2003-04-24
July, 2003	EIR	MERCK SERONO SPA - EIR, 2003-07-21
May, 2007	FDA 483 Response	Central Admixture Pharmacy Services, Inc. - Form 483R, 2007-06-15
October, 2007	FDA 483	Leading Pharma, LLC - Form 483, 2007-10-23
April, 2000	FDA 483	TEVA Pharmaceuticals USA Inc - Form 483, 2000-04-26
December, 2003	FDA 483 Response	Lilly France - Form 483R, 2004-02-18
July, 2003	FDA 483	MERCK SERONO SPA - Form 483, 2003-07-21
November, 2001	EIR	Ivax Pharmaceuticals Inc - EIR, 2001-11-29
September, 2001	FDA 483 Response	The P.F. Laboratories Inc. - Form 483R, 2001-09-26
June, 2001	EIR	Fermion Oy - EIR, 2001-06-21
December, 2005	FDA 483	Merck, Inc. - Form 483, 2005-12-14
October, 2003	FDA 483	Contract Coating Inc. - Form 483, 2003-10-10
February, 2008	EIR	Hoffmann La Roche Inc - EIR, 2008-02-05
April, 2003	EIR	Penick Corp - EIR, 2003-04-03
January, 2023	FDA 483	Jamol Laboratories, Inc. - Form 483, 2023-01-12
July, 2009	FDA 483	Ingenus Pharmaceuticals NJ, LLC - Form 483, 2009-07-07
February, 2013	EIR	Actavis Elizabeth LLC - EIR, 2013-02-15
June, 2000	EIR	Halo Pharmaceutical Inc - EIR, 2000-06-20
May, 2001	FDA 483	SGS North America Inc. - Form 483, 2001-05-23
April, 2004	FDA 483	Hikma Pharmaceuticals USA, Inc. - Form 483, 2004-04-15
June, 2003	FDA 483 Response	Unigene Laboratories, Inc. - Form 483R, 2003-06-27
June, 2012	FDA 483	AustarPharma, LLC - Form 483, 2012-06-05
December, 2007	FDA 483	Ranbaxy, Inc. - Form 483, 2007-12-19
September, 2009	FDA 483	MPL Laboratories - Form 483, 2009-09-18
April, 2000	EIR	TEVA Pharmaceuticals USA Inc - EIR, 2000-04-26
February, 2011	FDA 483	Hoffmann La Roche Inc - Form 483, 2011-02-04
June, 2000	FDA 483 Response	Halo Pharmaceutical Inc - Form 483R, 2000-07-13
June, 2002	FDA 483 Response	Ivax Pharmaceuticals Inc - Form 483R, 2002-07-10
March, 2009	FDA 483	Actavis Totowa LLC - Form 483, 2009-03-31
August, 2000	FDA 483 Response	Halo Pharmaceutical Inc - Form 483R, 2000-08-29
July, 2003	FDA 483	NPBI International BV - Form 483, 2003-07-11
October, 2003	EIR	Contract Coating Inc. - EIR, 2003-10-10
November, 2000	EIR	Novus Fine Chemicals - EIR, 2000-11-27
August, 2009	FDA 483	Hoffmann La Roche Inc - Form 483, 2009-08-18
June, 2013	EIR	Leading Pharma, LLC - EIR, 2013-06-12
August, 2006	FDA 483	Elite Laboratories, Inc. - Form 483, 2006-08-04
October, 2003	FDA 483 Response	Contract Coating Inc. - Form 483R, 2004-01-02
July, 2004	EIR	Mead Johnson & Company, LLC - EIR, 2004-07-23
December, 2003	EIR	Lilly France - EIR, 2003-12-08
February, 2020	EIR	SOLARA ACTIVE PHARMA SCIENCES LIMITED - EIR, 2020-02-21
November, 2000	FDA 483	Novus Fine Chemicals - Form 483, 2000-11-27
January, 2003	FDA 483	Actavis Elizabeth LLC - Form 483, 2003-01-15
July, 2007	EIR	Amneal Pharmaceuticals, LLC - EIR, 2007-07-17
February, 2013	FDA 483	Actavis Elizabeth LLC - Form 483, 2013-02-15
September, 2010	EIR	Novartis Pharmaceuticals Corporation - EIR, 2010-09-03
October, 2001	FDA 483 Response	Watson Pharma, Inc. - Form 483R, 2001-12-03
July, 2004	FDA 483 Response	Mead Johnson & Company, LLC - Form 483R, 2004-08-05
September, 2005	FDA 483	Eli Lilly And Co. Limited - Form 483, 2005-09-15
November, 2022	EIR	CAMBREX PROFARMACO MILANO SRL - EIR, 2022-12-22
July, 2007	FDA 483 Response	Amneal Pharmaceuticals, LLC - Form 483R, 2007-08-07
September, 2003	FDA 483	Ingenus Pharmaceuticals NJ, LLC - Form 483, 2003-09-19
October, 2002	FDA 483	DMV International - Form 483, 2002-10-17
April, 2003	FDA 483	Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - Form 483, 2003-04-24
July, 2008	FDA 483	Halo Pharmaceutical Inc - Form 483, 2008-07-29
May, 2005	FDA 483	Hoffmann La Roche Inc - Form 483, 2005-05-27
March, 2000	FDA 483	I S P Van Dyk Inc - Form 483, 2000-03-09
June, 2004	FDA 483	Pliva, Inc. - Form 483, 2004-06-02
November, 2000	EIR	McNeil PPC Inc. - EIR, 2000-11-08
November, 2001	FDA 483	Ivax Pharmaceuticals Inc - Form 483, 2001-11-29
May, 2003	EIR	Baxter Healthcare Corporation - EIR, 2003-05-12
June, 2000	EIR	Knoll Pharmaceutical Company - EIR, 2000-06-13
June, 2013	FDA 483	Leading Pharma, LLC - Form 483, 2013-06-12
August, 2013	FDA 483	Novel Laboratories, Inc. - Form 483, 2013-09-11
March, 2012	EIR	Teva Pharmaceuticals USA, Inc. - EIR, 2012-03-30
August, 2000	FDA 483	Halo Pharmaceutical Inc - Form 483, 2000-08-04
June, 2004	EIR	Pliva, Inc. - EIR, 2004-06-02
December, 2000	FDA 483	Reed-Lane, Inc. - Form 483, 2000-12-15
March, 2001	FDA 483 Response	Actavis Elizabeth LLC - Form 483R, 2001-03-23
May, 2009	FDA 483	Pliva, Inc. - Form 483, 2009-05-05
February, 2000	EIR	Frutarom USA Inc. - EIR, 2000-02-16
October, 2003	FDA 483 Response	Halo Pharmaceutical Inc - Form 483R, 2003-11-05
January, 2005	EIR	Aphena Pharma Solutions - EIR, 2005-01-25
June, 2000	FDA 483	Knoll Pharmaceutical Company - Form 483, 2000-06-20
March, 2001	EIR	Actavis Elizabeth LLC - EIR, 2001-03-12
May, 2005	FDA 483 Response	Hoffmann La Roche Inc - Form 483R, 2005-06-28
August, 2010	FDA 483	Contract Coating Inc. - Form 483, 2010-08-02
July, 2013	EIR	JAK Diversified II, Inc. dba Multi-Pak Packaging - EIR, 2013-07-22
August, 2013	FDA 483	ImprimisRx NJ - Form 483, 2013-08-19
October, 2003	EIR	Halo Pharmaceutical Inc - EIR, 2003-10-24
March, 2003	EIR	Ivax Pharmaceuticals Inc - EIR, 2003-03-07
December, 2010	FDA 483	Unipack LLC - Form 483, 2010-12-08
June, 2003	FDA 483	Unigene Laboratories, Inc. - Form 483, 2003-06-16
May, 2005	EIR	Hoffmann La Roche Inc - EIR, 2005-05-27
February, 2003	EIR	Sharp Corporation - EIR, 2003-02-21
February, 2000	EIR	McNeil PPC Inc. - EIR, 2000-02-09
May, 2007	FDA 483	Central Admixture Pharmacy Services, Inc. - Form 483, 2007-05-08
August, 2000	EIR	Halo Pharmaceutical Inc - EIR, 2000-08-04
August, 2003	FDA 483	Actavis Totowa LLC - Form 483, 2003-08-21
October, 2001	FDA 483	Watson Pharma, Inc. - Form 483, 2001-10-30
September, 2002	EIR	Barr Laboratories, Inc. - EIR, 2002-09-06
May, 2008	FDA 483	Actavis Elizabeth LLC - Form 483, 2008-05-21
June, 2002	EIR	Ivax Pharmaceuticals Inc - EIR, 2002-06-20
December, 2000	EIR	Reed-Lane, Inc. - EIR, 2000-12-15
April, 2003	FDA 483 Response	Penick Corp - Form 483R, 2003-04-10
August, 2003	EIR	Actavis Totowa LLC - EIR, 2003-08-21
September, 2001	FDA 483	The P.F. Laboratories Inc. - Form 483, 2001-09-21
July, 2007	FDA 483	Amneal Pharmaceuticals, LLC - Form 483, 2007-07-17
January, 2002	EIR	Merck Sharp & Dohme LLC - EIR, 2002-01-28
May, 2018	EIR	HOVIONE FARMACIENCIA, S.A. - EIR, 2018-05-18

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more